{"transactions":[{"id":729593,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T23:58:45.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":false,"shares":18880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18880},"source":{"system":"sec-edgar","filing":"0001104659-26-076930","document":"tm2618639-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076930/tm2618639-8_4seq1.xml","form_type":"4"}},{"id":729592,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T23:58:45.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":14180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":14180,"derivative":{"underlying":"Common Stock","underlying_shares":14180},"source":{"system":"sec-edgar","filing":"0001104659-26-076930","document":"tm2618639-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076930/tm2618639-8_4seq1.xml","form_type":"4"}},{"id":729591,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T23:58:45.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":21270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":21270,"derivative":{"exercise_price":9.13,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":21270},"source":{"system":"sec-edgar","filing":"0001104659-26-076930","document":"tm2618639-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076930/tm2618639-8_4seq1.xml","form_type":"4"}},{"id":729590,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T23:58:45.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":true,"shares":18880,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":47370,"source":{"system":"sec-edgar","filing":"0001104659-26-076930","document":"tm2618639-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076930/tm2618639-8_4seq1.xml","form_type":"4"}},{"id":731931,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T20:08:36.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":39715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":39715,"derivative":{"exercise_price":5.67,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":39715},"source":{"system":"sec-edgar","filing":"0001313397-26-000002","document":"wk-form4_1781813313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000131339726000002/wk-form4_1781813313.xml","form_type":"4"}},{"id":731930,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:08:36.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":26455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program."}],"balance_after":439998,"source":{"system":"sec-edgar","filing":"0001313397-26-000002","document":"wk-form4_1781813313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000131339726000002/wk-form4_1781813313.xml","form_type":"4"}},{"id":802608,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T20:32:27.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":24367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":343022,"source":{"system":"sec-edgar","filing":"0000905148-26-001788","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826001788/form4.xml","form_type":"4"}},{"id":1011558,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-10-30T20:30:19.000Z","date":"2025-10-29","kind":"exercise","planned":false,"acquired":false,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the October 29, 2022 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the October 29, 2022 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Restricted Stock Units","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0001104659-25-104413","document":"tm2529852-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925104413/tm2529852-1_4seq1.xml","form_type":"4"}},{"id":1011557,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-30T20:30:19.000Z","date":"2025-10-29","kind":"exercise","planned":false,"acquired":true,"shares":3800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":28490,"source":{"system":"sec-edgar","filing":"0001104659-25-104413","document":"tm2529852-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925104413/tm2529852-1_4seq1.xml","form_type":"4"}},{"id":1103167,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:40:56.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":18884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":18884,"derivative":{"underlying":"Common Stock","underlying_shares":18884},"source":{"system":"sec-edgar","filing":"0001104659-25-062196","document":"tm2518838-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925062196/tm2518838-6_4seq1.xml","form_type":"4"}},{"id":1103166,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:40:56.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":28326,"price":6.42,"value":181852.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":28326,"derivative":{"exercise_price":6.42,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":28326},"source":{"system":"sec-edgar","filing":"0001104659-25-062196","document":"tm2518838-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925062196/tm2518838-6_4seq1.xml","form_type":"4"}},{"id":1103638,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T00:42:03.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":54059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":54059,"derivative":{"exercise_price":3.61,"expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":54059},"source":{"system":"sec-edgar","filing":"0001628280-25-032729","document":"wk-form4_1750725716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828025032729/wk-form4_1750725716.xml","form_type":"4"}},{"id":1103637,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T00:42:03.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":41551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.  The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program."}],"balance_after":413543,"source":{"system":"sec-edgar","filing":"0001628280-25-032729","document":"wk-form4_1750725716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828025032729/wk-form4_1750725716.xml","form_type":"4"}},{"id":1103636,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T00:42:03.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":21468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program."}],"balance_after":371992,"source":{"system":"sec-edgar","filing":"0001628280-25-032729","document":"wk-form4_1750725716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828025032729/wk-form4_1750725716.xml","form_type":"4"}},{"id":1112403,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-06-14T01:40:27.000Z","date":"2025-06-12","kind":"exercise","planned":false,"acquired":false,"shares":10420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":10420},"source":{"system":"sec-edgar","filing":"0001593968-25-000759","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000759/primary_01.xml","form_type":"4"}},{"id":1112402,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-14T01:40:27.000Z","date":"2025-06-12","kind":"exercise","planned":false,"acquired":true,"shares":10420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24690,"source":{"system":"sec-edgar","filing":"0001593968-25-000759","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000759/primary_01.xml","form_type":"4"}},{"id":1160923,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-02T21:09:12.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":79592,"derivative":{"exercise_price":0.95,"expiration_date":"2035-04-29","underlying":"Common Stock","underlying_shares":79592},"source":{"system":"sec-edgar","filing":"0000905148-25-001430","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001430/form4.xml","form_type":"4"}},{"id":1160922,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-02T21:09:12.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":318655,"source":{"system":"sec-edgar","filing":"0000905148-25-001430","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001430/form4.xml","form_type":"4"}},{"id":1299974,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-17T21:44:49.000Z","date":"2025-01-16","kind":"exercise","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.55,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001628280-25-001849","document":"wk-form4_1737150282.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828025001849/wk-form4_1737150282.xml","form_type":"4"}},{"id":1299973,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T21:44:49.000Z","date":"2025-01-16","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":0.55,"value":55000.0,"ownership":{"direct":true},"balance_after":350524,"source":{"system":"sec-edgar","filing":"0001628280-25-001849","document":"wk-form4_1737150282.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828025001849/wk-form4_1737150282.xml","form_type":"4"}},{"id":1319050,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-01-02T21:52:22.000Z","date":"2024-10-29","kind":"exercise","planned":false,"acquired":false,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":3800,"derivative":{"exercise_price":0,"expiration_date":"2032-10-29","underlying":"Common Stock","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0001593968-25-000012","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000012/primary_01.xml","form_type":"4"}},{"id":1319049,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-01-02T21:52:22.000Z","date":"2024-10-29","kind":"exercise","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14270,"source":{"system":"sec-edgar","filing":"0001593968-25-000012","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000012/primary_01.xml","form_type":"4"}},{"id":1477196,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-17T22:54:37.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":40243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":40243,"derivative":{"exercise_price":6.35,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":40243},"source":{"system":"sec-edgar","filing":"0001628280-24-028604","document":"wk-form4_1718664869.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828024028604/wk-form4_1718664869.xml","form_type":"4"}},{"id":1477195,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-17T22:54:37.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":12204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program."}],"balance_after":250524,"source":{"system":"sec-edgar","filing":"0001628280-24-028604","document":"wk-form4_1718664869.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828024028604/wk-form4_1718664869.xml","form_type":"4"}},{"id":1479717,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-06-14T20:05:38.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":10420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10420,"derivative":{"exercise_price":0,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":10420},"source":{"system":"sec-edgar","filing":"0001593968-24-000860","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000860/primary_01.xml","form_type":"4"}},{"id":1479716,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T20:05:38.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":15630,"price":15.86,"value":247891.8,"ownership":{"direct":true},"balance_after":15630,"derivative":{"exercise_price":15.86,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":15630},"source":{"system":"sec-edgar","filing":"0001593968-24-000860","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000860/primary_01.xml","form_type":"4"}},{"id":1479715,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-06-14T20:05:38.000Z","date":"2024-06-12","kind":"exercise","planned":false,"acquired":false,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-06-12","expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":6670},"source":{"system":"sec-edgar","filing":"0001593968-24-000860","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000860/primary_01.xml","form_type":"4"}},{"id":1479714,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-14T20:05:38.000Z","date":"2024-06-12","kind":"exercise","planned":false,"acquired":true,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10470,"source":{"system":"sec-edgar","filing":"0001593968-24-000860","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000860/primary_01.xml","form_type":"4"}},{"id":1480383,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T21:31:50.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":35181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":35181,"derivative":{"exercise_price":1.72,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":35181},"source":{"system":"sec-edgar","filing":"0000905148-24-001714","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514824001714/form4.xml","form_type":"4"}},{"id":1480382,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-13T21:31:50.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":41143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":239151,"source":{"system":"sec-edgar","filing":"0000905148-24-001714","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514824001714/form4.xml","form_type":"4"}},{"id":1691508,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-03T23:03:03.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":24762,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted shares of common stock in lieu of cash for board services for 2024. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $2.81 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to January 1, 2024."}],"balance_after":198008,"source":{"system":"sec-edgar","filing":"0001140361-24-000494","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036124000494/form4.xml","form_type":"4"}},{"id":1743547,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-13T22:42:25.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vest on the one-year anniversary of the date of grant."}],"balance_after":173246,"source":{"system":"sec-edgar","filing":"0001140361-23-052986","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123052986/form4.xml","form_type":"4"}},{"id":1753390,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-10-31T20:43:35.000Z","date":"2023-10-29","kind":"exercise","planned":false,"acquired":false,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the October 29, 2022 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the October 29, 2022 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":7600,"derivative":{"underlying":"Restricted Stock Units","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0001209191-23-053952","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123053952/doc4.xml","form_type":"4"}},{"id":1753389,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-31T20:43:35.000Z","date":"2023-10-29","kind":"exercise","planned":false,"acquired":true,"shares":3800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":3800,"source":{"system":"sec-edgar","filing":"0001209191-23-053952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123053952/doc4.xml","form_type":"4"}},{"id":1825598,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:18:46.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":23839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":23839,"derivative":{"exercise_price":6.36,"expiration_date":"2031-01-26","underlying":"Series A Common Stock","underlying_shares":23839},"source":{"system":"sec-edgar","filing":"0001104659-23-082732","document":"tm2321276-20_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1313397/000110465923082732/tm2321276-20_4seq1.xml","form_type":"4"}},{"id":1825597,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:18:46.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":6.36,"expiration_date":"2031-01-26","underlying":"Common Stock","underlying_shares":23839},"source":{"system":"sec-edgar","filing":"0001104659-23-082732","document":"tm2321276-20_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1313397/000110465923082732/tm2321276-20_4seq1.xml","form_type":"4"}},{"id":1825596,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:18:46.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":23216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":23216,"derivative":{"exercise_price":6.36,"expiration_date":"2029-04-27","underlying":"Series A Common Stock","underlying_shares":23216},"source":{"system":"sec-edgar","filing":"0001104659-23-082732","document":"tm2321276-20_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1313397/000110465923082732/tm2321276-20_4seq1.xml","form_type":"4"}},{"id":1825595,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:18:46.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":6.36,"expiration_date":"2029-04-27","underlying":"Common Stock","underlying_shares":23216},"source":{"system":"sec-edgar","filing":"0001104659-23-082732","document":"tm2321276-20_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1313397/000110465923082732/tm2321276-20_4seq1.xml","form_type":"4"}},{"id":1825594,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:18:46.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":1976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":1976,"derivative":{"exercise_price":23.05,"expiration_date":"2025-03-09","underlying":"Series A Common Stock","underlying_shares":1976},"source":{"system":"sec-edgar","filing":"0001104659-23-082732","document":"tm2321276-20_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1313397/000110465923082732/tm2321276-20_4seq1.xml","form_type":"4"}},{"id":1825593,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-20T20:18:46.000Z","date":"2023-07-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option are fully vested and exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":23.05,"expiration_date":"2025-03-09","underlying":"Common Stock","underlying_shares":1976},"source":{"system":"sec-edgar","filing":"0001104659-23-082732","document":"tm2321276-20_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1313397/000110465923082732/tm2321276-20_4seq1.xml","form_type":"4"}},{"id":1851967,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T22:30:33.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":49237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":49237,"derivative":{"exercise_price":3.92,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":49237},"source":{"system":"sec-edgar","filing":"0001628280-23-022556","document":"wk-form4_1686954623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828023022556/wk-form4_1686954623.xml","form_type":"4"}},{"id":1851966,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T22:30:33.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":18494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program."}],"balance_after":238320,"source":{"system":"sec-edgar","filing":"0001628280-23-022556","document":"wk-form4_1686954623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828023022556/wk-form4_1686954623.xml","form_type":"4"}},{"id":1857764,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-13T20:48:27.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":6670,"derivative":{"underlying":"Common Stock","underlying_shares":6670},"source":{"system":"sec-edgar","filing":"0001209191-23-036760","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036760/doc4.xml","form_type":"4"}},{"id":1857763,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-13T20:48:27.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":7710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\") will vest one (1) year from the June 12, 2023 grant date (the \"Grant Date\") subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":7710,"derivative":{"exercise_price":7.78,"exercise_date":"2024-06-12","expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":7710},"source":{"system":"sec-edgar","filing":"0001209191-23-036760","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036760/doc4.xml","form_type":"4"}},{"id":1915530,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":true,"officer_title":"Interim CEO and President"}}],"security":"Common Stock","published_at":"2023-04-22T00:20:24.000Z","date":"2023-04-19","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vest on the one-year anniversary of the date of grant."}],"balance_after":138246,"source":{"system":"sec-edgar","filing":"0001140361-23-019675","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123019675/form4.xml","form_type":"4"}},{"id":2055514,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-12T22:34:03.000Z","date":"2023-01-11","kind":"grant","acquired":true,"shares":20822,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted shares of common stock in lieu of cash for board services for 2023.  The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share).  The average fair market value was $3.07 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to January 11, 2023."}],"balance_after":88246,"source":{"system":"sec-edgar","filing":"0001140361-23-001514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123001514/form4.xml","form_type":"4"}},{"id":2128840,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-11-01T21:10:31.000Z","date":"2022-10-29","kind":"grant","acquired":true,"shares":11400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service on the Company's Board of Directors through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service on the Company's Board of Directors through such vesting date."}],"balance_after":11400,"derivative":{"underlying":"Common Stock","underlying_shares":11400},"source":{"system":"sec-edgar","filing":"0001209191-22-055080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122055080/doc4.xml","form_type":"4"}},{"id":2128839,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-11-01T21:10:31.000Z","date":"2022-10-29","kind":"grant","acquired":true,"shares":17095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), will vest with respect to one-third (1/3) of the shares on each of the first three (3) anniversaries of the October 29, 2022 grant date (the \"Grant Date\"), in each case subject to continued service on the Company's Board of Directors through such vesting date."}],"balance_after":17095,"derivative":{"exercise_price":23.02,"exercise_date":"2023-10-29","expiration_date":"2032-10-29","underlying":"Common Stock","underlying_shares":17095},"source":{"system":"sec-edgar","filing":"0001209191-22-055080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122055080/doc4.xml","form_type":"4"}},{"id":2144009,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Series B Warrant (right to buy)","published_at":"2022-10-04T13:00:29.000Z","date":"2022-10-03","kind":"other","acquired":false,"shares":3148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The expiration date of the Series B Warrants occurred on the later of (x) the Reservation Date (as defined in the Series B Warrants) and (y) the date on which the Series B Warrant has been exercised in full."}],"balance_after":0,"derivative":{"exercise_price":0.0001,"exercise_date":"2020-11-19","expiration_date":"2022-10-04","underlying":"Common Stock","underlying_shares":3148},"source":{"system":"sec-edgar","filing":"0001140361-22-035953","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036122035953/form4.xml","form_type":"4"}},{"id":2144008,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-10-04T13:00:29.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":3148,"price":0.0001,"value":0.3148,"ownership":{"direct":true},"balance_after":67424,"source":{"system":"sec-edgar","filing":"0001140361-22-035953","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036122035953/form4.xml","form_type":"4"}},{"id":2211586,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-07-06T21:58:25.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":15841,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person was granted shares of common stock in lieu of cash for board services for the second half of 2022.  The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock for the 30 consecutive trading days ending on and including the last trading day prior to the grant date (rounded down to the nearest whole share).  The average fair market value was $2.02 per share, the average of the closing price of the common stock for the 30 consecutive trading days prior to July 1, 2022."}],"balance_after":64276,"source":{"system":"sec-edgar","filing":"0001140361-22-025286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036122025286/form4.xml","form_type":"4"}},{"id":2211585,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-07-06T21:58:25.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":7812,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted shares of common stock in lieu of cash for board services for the second quarter of 2022.  The number of shares of common stock was determined by dividing (A) the aggregate amount of the retainer paid for board services for such fiscal quarter, by (B) the fair market value of the common stock on the last day of the fiscal quarter (rounded down to the nearest whole share).  The fair market value was $1.92 per share, the closing price of the common stock on June 30, 2022."}],"balance_after":48435,"source":{"system":"sec-edgar","filing":"0001140361-22-025286","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036122025286/form4.xml","form_type":"4"}},{"id":2227512,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T20:22:45.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.548,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567619-22-013086","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000156761922013086/doc1.xml","form_type":"4"}},{"id":2227511,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T20:22:45.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":132299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program.  The Reporting Person elected to receive stock in lieu of cash as permitted under the program."}],"balance_after":219826,"source":{"system":"sec-edgar","filing":"0001567619-22-013086","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000156761922013086/doc1.xml","form_type":"4"}},{"id":2231287,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-06-15T20:01:46.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":1.93,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-22-023052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036122023052/form4.xml","form_type":"4"}},{"id":2303888,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-04-05T13:12:26.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":4629,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted shares of common stock in lieu of cash for board services for the first quarter of 2022.  The number of shares of common stock was determined by dividing (A) the aggregate amount of the retainer paid for board services for such fiscal quarter, by (B) the fair market value of the common stock on the last day of the fiscal quarter (rounded down to the nearest whole share).  The fair market value was $3.24 per share, the closing price of the common stock on March 31, 2022."}],"balance_after":40623,"source":{"system":"sec-edgar","filing":"0001140361-22-013060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036122013060/form4.xml","form_type":"4"}},{"id":2443299,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-01-05T21:01:53.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":4021,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted common stock in lieu of cash for Q4 2021 Board services.  The number of shares of Common Stock having an aggregate Fair Market Value equal to the aggregate amount of the Retainers for such fiscal quarter, determined by dividing (A) the aggregate amount of the Retainers by (B) the Fair Market Value of the Common Stock on last day of the fiscal quarter (rounded down to the nearest whole share).  The Fair Market Value was $3.73 per share, the closing price of the Company's stock on December 31, 2021."}],"balance_after":35994,"source":{"system":"sec-edgar","filing":"0001140361-22-000659","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036122000659/form4.xml","form_type":"4"}},{"id":2551576,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-04T20:01:53.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":2912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted common stock in lieu of cash for Q3 2021 Board services.  The number of shares of Common Stock having an aggregate Fair Market Value equal to the aggregate amount of the Retainers for such fiscal quarter, determined by dividing (A) the aggregate amount of the Retainers by (B) the Fair Market Value of the Common Stock on last day of the fiscal quarter (rounded down to the nearest whole share).  The Fair Market Value was $5.15 per share, the closing price of the Company's stock on September 30, 2021."}],"balance_after":31973,"source":{"system":"sec-edgar","filing":"0001140361-21-033450","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036121033450/form4.xml","form_type":"4"}},{"id":2644025,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-07-02T20:01:20.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":2840,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted common stock in lieu of cash for Q2 2021 Board services.  The number of shares of Common Stock having an aggregate Fair Market Value equal to the aggregate amount of the Retainers for such fiscal quarter, determined by dividing (A) the aggregate amount of the Retainers by (B) the Fair Market Value of the Common Stock on last day of the fiscal quarter (rounded down to the nearest whole share).  The Fair Market Value was $5.28 per share, the closing price of the Company's stock on June 30, 2021."}],"balance_after":29061,"source":{"system":"sec-edgar","filing":"0001140361-21-023334","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036121023334/form4.xml","form_type":"4"}},{"id":2660783,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-21T20:10:04.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":32765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":32765,"derivative":{"exercise_price":7.31,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":32765},"source":{"system":"sec-edgar","filing":"0001567619-21-012429","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000156761921012429/doc1.xml","form_type":"4"}},{"id":2660782,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T20:10:04.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":9917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program.  The Reporting Person elected to receive stock in lieu of cash as permitted under the program."}],"balance_after":87527,"source":{"system":"sec-edgar","filing":"0001567619-21-012429","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000156761921012429/doc1.xml","form_type":"4"}},{"id":2675363,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-06-09T22:14:54.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":5.74,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-21-020422","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036121020422/form4.xml","form_type":"4"}},{"id":2757294,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-05T21:43:22.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":2581,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted common stock in lieu of cash for Q1 2021 Board services.  The number of shares of Common Stock having an aggregate fair market value equal to the aggregate amount of the Retainers for such fiscal quarter, determined by dividing (A) the aggregate amount of the Retainers by (B) the Fair Market Value of the Common Stock on last day of the fiscal quarter (rounded down to the nearest whole share).  The Fair Market Value was $5.81 per share, the closing price of the Company's stock on March 31, 2021."}],"balance_after":26221,"source":{"system":"sec-edgar","filing":"0001140361-21-011670","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036121011670/form4.xml","form_type":"4"}},{"id":2965947,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Series B Warrant (right to buy)","published_at":"2020-11-26T01:12:38.000Z","date":"2020-11-19","kind":"purchase","acquired":true,"shares":3148,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to adjustment based on certain price reset provisions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $100,000."}],"balance_after":3148,"derivative":{"exercise_price":0.0001,"exercise_date":"2020-11-19","expiration_date":"2022-01-28","underlying":"Common Stock","underlying_shares":3148},"source":{"system":"sec-edgar","filing":"0001140361-20-026657","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036120026657/form4.xml","form_type":"4"}},{"id":2965946,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Series A Warrant (right to buy)","published_at":"2020-11-26T01:12:38.000Z","date":"2020-11-19","kind":"purchase","acquired":true,"shares":26789,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Subject to adjustment based on certain price reset provisions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $100,000."}],"balance_after":26789,"derivative":{"exercise_price":4.4795,"exercise_date":"2020-11-19","expiration_date":"2025-11-19","underlying":"Common Stock","underlying_shares":26789},"source":{"system":"sec-edgar","filing":"0001140361-20-026657","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036120026657/form4.xml","form_type":"4"}},{"id":2965945,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-26T01:12:38.000Z","date":"2020-11-19","kind":"purchase","acquired":true,"shares":17730,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $100,000."}],"balance_after":23640,"source":{"system":"sec-edgar","filing":"0001140361-20-026657","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036120026657/form4.xml","form_type":"4"}},{"id":2980858,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T22:22:04.000Z","date":"2020-11-11","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"16,666 shares vest each twelve month period ending October 31, 2021 and October 31, 2022 and the balance vest October 31, 2023."}],"balance_after":50000,"derivative":{"exercise_price":4.05,"expiration_date":"2030-11-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-20-025549","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036120025549/form4.xml","form_type":"4"}},{"id":2988081,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-09T21:56:32.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":5910,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired the shares of the common stock of Rexahn Pharmaceuticals, Inc. (\"Rexahn\") on November 5, 2020, in exchange for shares of the common stock of Ocuphire Pharma, Inc. (\"Ocuphire\"), pursuant to the Agreement and Plan of Merger and Reorganization, dated as of June 17, 2020, as amended, between Rexahn, Razor Merger Sub, Inc., and Ocuphire pursuant to which Ocuphire became a wholly-owned subsidiary of Rexahn. Per the terms of the Merger Agreement, each share of Ocuphire common stock was converted into the right to receive 1.0565 shares of Rexahn common stock. Subsequent to the merger, the name of the issuer was changed from Rexahn Pharmaceuticals, Inc. to Ocuphire Pharma, Inc."}],"balance_after":5910,"source":{"system":"sec-edgar","filing":"0001596771-20-000108","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000159677120000108/primary_doc.xml","form_type":"4"}},{"id":3113283,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T22:20:29.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":23500,"derivative":{"exercise_price":7.31,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001567619-20-012029","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000156761920012029/doc1.xml","form_type":"4"}},{"id":3113282,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-11T22:20:29.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":9233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program.  The Reporting Person elected to receive stock in lieu of cash as permitted under the program."}],"balance_after":77610,"source":{"system":"sec-edgar","filing":"0001567619-20-012029","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000156761920012029/doc1.xml","form_type":"4"}},{"id":3487627,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-17T20:34:25.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":50000,"derivative":{"exercise_price":2.74,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-19-013483","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000156761919013483/doc1.xml","form_type":"4"}},{"id":3487626,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T20:34:25.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":24635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program.  The Reporting Person elected to receive stock in lieu of cash as permitted under the program."}],"balance_after":68377,"source":{"system":"sec-edgar","filing":"0001567619-19-013483","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000156761919013483/doc1.xml","form_type":"4"}},{"id":3496971,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2019-06-07T20:19:29.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":3537,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3537,"derivative":{"exercise_price":5.23,"exercise_date":"2020-06-06","expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":3537},"source":{"system":"sec-edgar","filing":"0001140361-19-010676","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036119010676/form4.xml","form_type":"4"}},{"id":3880351,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2018-06-29T20:34:08.000Z","date":"2018-06-28","kind":"grant","acquired":true,"shares":39742,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39742,"derivative":{"exercise_price":1.46,"exercise_date":"2019-06-28","expiration_date":"2028-06-28","underlying":"Common Stock","underlying_shares":39742},"source":{"system":"sec-edgar","filing":"0001140361-18-030728","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036118030728/form4.xml","form_type":"4"}},{"id":3892486,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T22:56:20.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":4.03,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-18-028861","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000114036118028861/doc1.xml","form_type":"4"}},{"id":3892485,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-15T22:56:20.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":16749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program."}],"balance_after":43742,"source":{"system":"sec-edgar","filing":"0001140361-18-028861","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000114036118028861/doc1.xml","form_type":"4"}},{"id":4286935,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-09T23:04:42.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":4.3,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-17-024617","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000114036117024617/doc1.xml","form_type":"4"}},{"id":4286934,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-09T23:04:42.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":15697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program."}],"balance_after":26993,"source":{"system":"sec-edgar","filing":"0001140361-17-024617","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437402/000114036117024617/doc1.xml","form_type":"4"}},{"id":4353358,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":36118,"kind":"person","name":"Rodgers Richard J","position":1,"cik":"0001313397","reported_name":"Rodgers Richard J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2017-04-12T21:25:29.000Z","date":"2017-04-11","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":110000,"derivative":{"exercise_price":0.618,"exercise_date":"2018-04-11","expiration_date":"2027-04-11","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001140361-17-015709","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036117015709/form4.xml","form_type":"4"}}]}